Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-02-08
DOI
10.3389/fimmu.2017.00070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correction: SOCS3 Deficiency Promotes M1 Macrophage Polarization and Inflammation
- (2016) Hongwei Qin et al. JOURNAL OF IMMUNOLOGY
- Expression of SOCS1 and CXCL12 Proteins in Primary Breast Cancer Are Associated with Presence of Circulating Tumor Cells in Peripheral Blood
- (2016) Bozena Smolkova et al. Translational Oncology
- Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma
- (2016) Braden C. McFarland et al. Oncotarget
- MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation
- (2015) XUGUANG WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Recombinant Human Granulocyte Colony-Stimulating Factor Promotes Preinvasive and Invasive Estrogen Receptor-Positive Tumor Development in MMTV-erbB2 Mice
- (2015) Chun Ling Zhao et al. Journal of Breast Cancer
- SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells
- (2015) H. Yu et al. Cancer Immunology Research
- Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3
- (2014) B. Kneitz et al. CANCER RESEARCH
- SOCS proteins in regulation of receptor tyrosine kinase signaling
- (2014) Julhash U. Kazi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Unique Expression of Suppressor of Cytokine Signaling 3 Is Essential for Classical Macrophage Activation in Rodents In Vitro and In Vivo
- (2014) Yu Liu et al. JOURNAL OF IMMUNOLOGY
- Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN- on STAT3 and Smads
- (2014) K. Tanaka et al. JOURNAL OF IMMUNOLOGY
- Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells
- (2014) Muriel David et al. Molecular Oncology
- SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model
- (2014) G Kim et al. ONCOGENE
- Inhibition of IL-6 family cytokines by SOCS3
- (2014) Jeffrey J. Babon et al. SEMINARS IN IMMUNOLOGY
- Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells
- (2013) Kazuki Shimada et al. CANCER SCIENCE
- SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer
- (2013) Diego Iglesias-Gato et al. CARCINOGENESIS
- miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
- (2013) Nicola Amodio et al. CELL CYCLE
- Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα+ tumorigenesis
- (2013) S R Chan et al. CELL DEATH AND DIFFERENTIATION
- SOCS3 Deletion in T Lymphocytes Suppresses Development of Chronic Ocular Inflammation via Upregulation of CTLA-4 and Expansion of Regulatory T Cells
- (2013) C.-R. Yu et al. JOURNAL OF IMMUNOLOGY
- Suppressor of Cytokine Signaling (SOCS) 5 Utilises Distinct Domains for Regulation of JAK1 and Interaction with the Adaptor Protein Shc-1
- (2013) Edmond M. Linossi et al. PLoS One
- miR-19a: An Effective Regulator of SOCS3 and Enhancer of JAK-STAT Signalling
- (2013) Aideen S. Collins et al. PLoS One
- Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer
- (2012) Steven D. Heys et al. BREAST CANCER RESEARCH AND TREATMENT
- IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer
- (2012) Yi Li et al. CARCINOGENESIS
- Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs
- (2012) Shuxia Song et al. EUROPEAN JOURNAL OF CANCER
- The development of IL-17/IFN-γ-double producing CTLs from Tc17 cells is driven by epigenetic suppression of Socs3 gene promoter
- (2012) Takayuki Satoh et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms
- (2012) Shen-meng Gao et al. EXPERIMENTAL HEMATOLOGY
- Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma
- (2012) P. Liang et al. HAEMATOLOGICA
- Suppression of Cytokine Signaling by SOCS3: Characterization of the Mode of Inhibition and the Basis of Its Specificity
- (2012) Jeffrey J. Babon et al. IMMUNITY
- RETRACTED: Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization
- (2012) Shaun Spence et al. IMMUNITY
- Enhancement of leptin receptor signaling by SOCS3 deficiency induces development of gastric tumors in mice
- (2012) K Inagaki-Ohara et al. ONCOGENE
- Evolution of JAK-STAT Pathway Components: Mechanisms and Role in Immune System Development
- (2012) Clifford Liongue et al. PLoS One
- MicroRNA-155 Modulates Treg and Th17 Cells Differentiation and Th17 Cell Function by Targeting SOCS1
- (2012) Rui Yao et al. PLoS One
- SOCS, Inflammation, and Autoimmunity
- (2012) Akihiko Yoshimura et al. Frontiers in Immunology
- Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4+ and CD8+ T cells
- (2011) Kristan D. Guenterberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction
- (2011) Kiyokazu Hiwatashi et al. CANCER LETTERS
- Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T CellsIn Situand Lymph Node Metastasis
- (2011) Jinpu Yu et al. Clinical & Developmental Immunology
- Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells
- (2011) Yoshihito Souma et al. INTERNATIONAL JOURNAL OF CANCER
- Role of SOCS1 in tumor progression and therapeutic application
- (2011) Jing Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia
- (2011) Vicent Guillem et al. LEUKEMIA RESEARCH
- Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells
- (2011) Hua Xiong et al. MOLECULAR CARCINOGENESIS
- Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells
- (2010) Gregory B Lesinski et al. BMC CANCER
- Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer
- (2010) Walid Sasi et al. BMC CANCER
- Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma
- (2010) Kota Iwahori et al. INTERNATIONAL JOURNAL OF CANCER
- Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases
- (2009) Hannes Neuwirt et al. AMERICAN JOURNAL OF PATHOLOGY
- Antigen Presentation by Dendritic Cells in Tumors Is Disrupted by Altered Metabolism that Involves Pyruvate Kinase M2 and Its Interaction with SOCS3
- (2009) Z. Zhang et al. CANCER RESEARCH
- Silencing ofSOCS1in macrophages suppresses tumor development by enhancing antitumor inflammation
- (2009) Masayuki Hashimoto et al. CANCER SCIENCE
- Epigenetic Alterations in Cholangiocarcinoma-Sustained IL-6/STAT3 Signaling in Cholangio- carcinoma due to SOCS3 Epigenetic Silencing
- (2009) Hajime Isomoto DIGESTION
- Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells
- (2009) P.-L. Kuo et al. MOLECULAR CANCER THERAPEUTICS
- SOCS regulation of the JAK/STAT signalling pathway
- (2008) Ben A. Croker et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now